Changing Treatment Strategy for Gastrinoma in Patients with Zollinger-Ellison Syndrome
Changing Treatment Strategy for Gastrinoma in Patients with Zollinger-Ellison Syndrome
复制标题
改变佐林格-埃里森综合征患者胃泌素瘤的治疗策略
DOI：
10.1007/s00268-005-0341-1
复制
发表时间：
2005
影响因子：
2.6
通讯作者：
S. Ota
中科院分区：
文献类型：
--
作者：
M. Imamura;I. Komoto;S. Ota
本文综述了近年来胃泌素瘤外科治疗的进展，尤其是选择性动脉促分泌素注射试验（SASI试验）和生长抑素受体显像（SRS）的发展，使胃泌素瘤外科治疗得到了迅速的发展。随着Zollinger-Ellison综合征患者胃泌素瘤根治性切除的增加，积累了一系列新的病理学发现，这些新发现也促进了Zollinger-Ellison综合征患者胃泌素瘤治疗策略的发展。
We overviewed the recent development of curative surgery for gastrinoma that has been rapidly improved since the development of new localization techniques, especially the selective arterial secretagogue injection test (SASI test) and somatostatin receptor scintigraphy (SRS). A number of new pathological findings of gastrinomas in patients with Zollinger-Ellison syndrome have been accumulated in accordance with the increase of curative resection of gastrinomas, and these new findings also have contributed to the progress of the treatment strategy for grastrinomas.
心内胃泌素瘤的手术切除。
DOI：
10.1016/s0003-4975(98)01205-3
发表时间：
1999
期刊：
The Annals of thoracic surgery
影响因子：
--
作者：
Noda,S;Norton,JA;Jensen,RT;GayJr,WA
通讯作者：
GayJr,WA